Neumora Therapeutics, Inc. (NMRA)
0.7519
+0.06
(+8.69%)
USD |
NASDAQ |
Sep 22, 11:22
Neumora Therapeutics Total Long Term Debt (Quarterly) : 52.95M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 52.95M |
| March 31, 2026 | 53.08M |
| December 31, 2025 | 54.72M |
| September 30, 2025 | 19.83M |
| June 30, 2025 | 19.79M |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.938M |
| Date | Value |
|---|---|
| December 31, 2023 | 1.853M |
| September 30, 2023 | 2.745M |
| June 30, 2023 | 3.497M |
| March 31, 2023 | 4.294M |
| December 31, 2022 | 5.072M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.723M |
| March 31, 2021 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| BioAge Labs, Inc. | 2.121M |
| LB Pharmaceuticals, Inc. | 4.373M |
| ANI Pharmaceuticals, Inc. | 610.49M |
| Corcept Therapeutics, Inc. | 7.504M |
| Veru, Inc. | 1.908M |